News

Canaccord Genuity appoints Dr. Julian Feneley as Head of Healthcare Investment Banking, Europe

19 March 2013

LONDON, 19 March 2013 – Canaccord Genuity is pleased to announce that Dr. Julian Feneley will be joining the company as Head of Healthcare Investment Banking, Europe.  Julian has over 20 years of healthcare industry experience as an investment banker and as a CEO.  He will lead Canaccord Genuity’s coverage of the European Healthcare sector from London and will report to Adrian Haxby, Head of European Investment Banking.

“We are very pleased to welcome Julian’s deep Healthcare expertise and experience to our growing Healthcare team.  He will play a key role in further strengthening our advisory capabilities in this important sector,” stated Alexis de Rosnay, CEO of Canaccord Genuity Limited. 

Prior to accepting the role at Canaccord Genuity, Julian held leadership positions at public and private companies and investment banks.  At JP Morgan, where he was a senior member of their Healthcare investment banking franchise in Europe, he advised on a number of pivotal cross-border transactions including the creation of Novartis, Pharmacia & Upjohn and AstraZeneca. He has supported clients across all healthcare sub-sectors including biotechnology, specialty pharmaceuticals, med-device, med-tech, diagnostics, and healthcare services, and worked on a broad range of transactions with companies at all stages of development. Julian has also led companies in the healthcare space in the US and the UK, including Britesmile, Inc. and Bioscience Managers (a biotechnology venture capital and corporate finance boutique). 

Dr. Feneley is a qualified medical doctor from Guy’s Hospital in London, and has worked extensively in both Europe and the US.  He has an M.B.B.S., Bachelors of Medicine, Bachelors of Surgery and Honours degree in Medicine and Physiology from London University. 

Adrian Haxby added: “Julian’s medical background and entrepreneurial approach make him an excellent addition to Canaccord Genuity’s Investment Banking team.”

Julian’s appointment follows the recruitment of Daniel Sharp and Dr. Matthijs Smith to the firm’s Life Sciences team in Melbourne in October 2012, and Harrison Wehner as Managing Director covering healthcare in Boston, who joined in November 2012 from Citigroup.

Back to Listing